Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;36(2):169-82.
doi: 10.1007/s00296-015-3367-1. Epub 2015 Sep 24.

Innate immune cells in the pathogenesis of primary systemic vasculitis

Affiliations
Review

Innate immune cells in the pathogenesis of primary systemic vasculitis

Durga Prasanna Misra et al. Rheumatol Int. 2016 Feb.

Abstract

Innate immune system forms the first line of defense against foreign substances. Neutrophils, eosinophils, erythrocytes, platelets, monocytes, macrophages, dendritic cells, γδ T cells, natural killer and natural killer T cells comprise the innate immune system. Genetic polymorphisms influencing the activation of innate immune cells predispose to development of vasculitis and influence its severity. Abnormally activated innate immune cells cross-talk with other cells of the innate immune system, present antigens more efficiently and activate T and B lymphocytes and cause tissue destruction via cell-mediated cytotoxicity and release of pro-inflammatory cytokines. These secreted cytokines further recruit other cells to the sites of vascular injury. They are involved in both the initiation as well as the perpetuation of vasculitis. Evidences suggest reversal of aberrant activation of immune cells in response to therapy. Understanding the role of innate immune cells in vasculitis helps understand the potential of therapeutic modulation of their activation to treat vasculitis.

Keywords: Innate immunity; Monocytes; Myeloid cells; Pathogenesis; Platelets; Vasculitis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1994 Sep;94(3):1134-40 - PubMed
    1. J Clin Invest. 1997 Sep 15;100(6):1416-24 - PubMed
    1. Clin Immunol. 2001 Jun;99(3):373-7 - PubMed
    1. Arch Pathol Lab Med. 2003 Jan;127(1):98-101 - PubMed
    1. Iran J Allergy Asthma Immunol. 2014 Aug;13(4):265-70 - PubMed

MeSH terms

Substances

LinkOut - more resources